Taiwanese contract chipmaker producing chips for Apple, NVIDIA and AMD
Principal Asia Pacific Dynamic Income Equity Fund
Shows where this fund stands in its group. Not investment advice · Data as of 3 Nov 2026
PRINCIPAL APDI-X invests through the master fund Principal Asia Pacific Dynamic Income Fund 98.85%
This fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
Data as of 30 Sep 2026 · Top 6 shown, the rest grouped as Other · per Principal fact sheet
No 1-year group rank yet
Each bar is one fund in the AIMC Asia Pacific Ex Japan group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 3 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | MAX |
|---|---|---|---|---|---|---|---|
| +10.20% | −1.17% | −1.05% | −3.58% | +3.63% | +2.33% | +17.92% | +0.57% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | −1.4 | +4.6 | +3.9 | −0.9 | +0.6 | +5.0 | −2.3 | +1.3 | +3.2 | −3.1 | −0.6 |
Largest drawdown in the selected period −21.31% Previous peak 8 Jun 2022 (NAV 20.3527) → Trough 25 Oct 2022 (NAV 16.0150) · Back to the previous peak on 9 Jul 2024, after 1 year 8 months
Currently −5.14% from the peak NAV of 20.7372 (7 Oct 2024)
Over 1 year, 33 funds have data · PRINCIPAL APDI-X has no data for this period yet
กองทุนมีนโยบายเน้นลงทุนในหน่วยลงทุนของกองทุน Principal Asia Pacific Dynamic Income Fund ที่จดทะเบียนในประเทศมาเลเซียเพียงกองทุนเดียว ซึ่งกองทุนหลัก (Master Fund) มีนโยบายจุดมุ่งหมายในการบริหารจัดการผลตอบแทนของกองทุนให้มีเสถียรภาพและเชิงบวกจากการลงทุนในภูมิภาคเอเชียแปซิฟิก (ยกเว้นประเทศญี่ปุ่น)… Its largest holdings are Principal Asia Pacific Dynamic Income Fund CPASUSD MK 98.85% (fact sheet 30 Sep 2026)
Risk level 6 of 8 (High risk). Since 20 May 2022, its NAV has fallen as much as −21.31% from its peak.
Actual total expense ratio (TER) 0.01% a year, against a ceiling of 3.75%. Management fee 0.00%. Front-end fee 0.00%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 1 THB, subsequent purchases 1 THB. Buy orders accepted until 14:00, sell orders until 14:00, and redemption proceeds are paid T+6
Hedged at the manager's discretion. As of 30 Sep 2026, 75.30% of the value of its foreign investments was hedged
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · PRINCIPAL APDI-X: no dividends, TER 0.01% · PRINCIPAL APDI-A: no dividends, TER 1.96% · PRINCIPAL APDI-C: no dividends, TER 1.96% · PRINCIPAL APDI-E: see the conditions in the prospectus · PRINCIPAL APDI-I: see the conditions in the prospectus · PRINCIPAL APDI-R: see the conditions in the prospectus · PRINCIPAL APDI-SSF: see the conditions in the prospectus
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Taiwanese contract chipmaker producing chips for Apple, NVIDIA and AMD
Makes Galaxy smartphones, TVs, home appliances and memory chips
South Korean memory chip maker, producing DRAM, NAND and the HBM paired with AI chips
Fund that trades on the stock exchange like a share, with its own fees
Owner of the Taobao, Tmall and Lazada shopping platforms, as well as Alibaba Cloud
Taiwanese company that designs Dimensity smartphone chips, as well as chips for TVs and connected devices
Chinese tech company that owns the WeChat chat app, online games such as Honor of Kings and cloud services
British bank that does most of its business in Asia, Africa and the Middle East, including Thailand
Retail loans, hire purchase and credit cards
Chinese company that researches, tests and makes drugs under contract for drug and biotech companies worldwide
Based on the master fund's share of this fund's value (98.85% as of 30 Sep 2026) × each stock's weight in the master fund · stocks as of 30 Sep 2026 · fact sheet from Principal · Illustrations are for explanation only, not individual stock recommendations
| · |
| +10.2* |
| 2023 | +6.9 | −5.9 | +1.2 | −1.4 | −3.6 | +2.4 | +3.0 | −4.4 | −2.6 | −4.5 | +6.1 | +3.9 | +0.2 |
| 2022 | · | · | · | · | +3.2 | −6.0 | −0.8 | +1.0 | −10.7 | −4.5 | +11.6 | −1.5 | −8.9* |